Treatment of Diabetic Neuropathy
A New Approach
Published on 6. July 1992
Book
Hardback
156 pages
978-0-443-04774-9 (ISBN)
Description
A review of the clinical problems of diabetic neuropathy and the use of a new agent, gamma-linolenic acid, in its treatment. Dealing with one of the latest advances in the field, this book should be of interest to specialists in diabetics and neurology.
A review of the clinical problems of diabetic neuropathy and the use of a new agent, gamma-linolenic acid, in its treatment. Dealing with one of the latest advances in the field, this book should be of interest to specialists in diabetics and neurology.
A review of the clinical problems of diabetic neuropathy and the use of a new agent, gamma-linolenic acid, in its treatment. Dealing with one of the latest advances in the field, this book should be of interest to specialists in diabetics and neurology.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
College/higher education
Professional and scholarly
Illustrations
25 line drawings, 15 half-tones, index
Dimensions
Height: 13 mm
Width: 242 mm
Weight
391 gr
ISBN-13
978-0-443-04774-9 (9780443047749)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Diabetic neuropathy - the diabetologist's view; diabetic neuropathy - a neurologist's view; essential fatty acids in relation to diabetes; responses to peripheral nerve conduction velocities to treatment with esential fatty acids in diabetic rats - possible mechanisms of action; effects of gamma-linolenic acide on nerve and muscle dysfunction in experimental diabetes - relation to vascular effects of prostanoid metabolism; gamma-linolenic acid and the metabolic basis of condiction disorders in experimental diabetes; effects of gamma-linolenic acid as evening primrose oil on blood rheology and haemostasis in daibetics - a ransomized, double-blind-placebo-controlled trial; a new model for diabetic neuropathy and a pilot controlled trial of gamma-linolenic acid; the effects of gamma-linolenic acid on diabetic neuropathy - a multicentre trial; a pilot study of gamma-linolenic acid in diabetic retinopathy.